Monitor for a prospectus supplement or 424B filing that would disclose actual offering size and pricing. Given the $17M market cap and shelf effectiveness, any sizable secondary offering could be meaningfully dilutive. Traders should watch for near-term pricing announcements.
Price Chart
Executive Summary
NewcelX Ltd.'s shelf registration statement on Form F-3 (File No. 333-284811) became effective on June 17, 2026, per this EFFECT notice. The company can now offer and sell securities (shares, warrants, units) from time to time at its discretion, creating a potential dilution overhang for the $17M market cap stock. No specific offering size or pricing details are disclosed in this filing.
Key Facts
- Effectiveness date: June 17, 2026
- Form F-3 shelf registration (File No. 333-284811) under the 1933 Act
- No offering size, share count, or pricing disclosed in the EFFECT notice
- Market cap: $17M — any future offering could be highly dilutive relative to current equity base
- Formerly known as NLS Pharmaceutics Ltd. (name change July 2019)
Financial Impact
Undisclosed — shelf allows future offerings of unspecified size; potential dilution overhang for a $17M market cap company
Risk Factors
- Potential dilutive equity offering at any time without further notice
- Small market cap amplifies dilution impact of any future issuance
- No stated use of proceeds or capital need disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002036 |
| Document: 9999999995-26-002036-index.html | 9999999995-26-002036 |
| Document: 9999999995-26-002036.txt | 9999999995-26-002036 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | EFFECT | $2.86 $3.08 | ▼ −7.52% | ▼ −8.19% | $2.55 (+10.84%) |
Sep 18, 2026 5w ago | 6-K | $2.97 $2.92 | ▲ +1.68% | ▲ +0.66% | $2.55 (+14.14%) |
Aug 27, 2026 8w ago | EFFECT | $3.42 $3.35 | ▲ +2.05% | ▲ +1.28% | $2.55 (+25.44%) |
Jul 31, 2026 12w ago | 6-K | $3.49 $3.31 | ▼ −5.16% | ▼ −8.67% | $2.55 (−26.93%) |
Jul 15, 2026 14w ago | 6-K | $3.93 $3.65 | ▼ −7.12% | ▼ −6.14% | $2.55 (−35.11%) |
Jul 8, 2026 15w ago | 6-K | $4.23 $3.98 | ▼ −5.91% | ▼ −6.77% | $2.55 (−39.72%) |
Jul 1, 2026 16w ago | 6-K | $3.85 $4.01 | ▲ +4.16% | ▲ +3.89% | $2.55 (−33.77%) |
Jun 30, 2026 16w ago | 6-K | $3.85 $4.01 | ▲ +4.16% | ▲ +3.89% | $2.55 (−33.77%) |
Jun 18, 2026 18w ago | EFFECT | $3.31 $3.55 | ▼ −7.25% | ▼ −8.92% | $2.55 (+22.96%) |
Jun 5, 2026 20w ago | 6-K | $3.24 $3.20 | ▼ −1.23% | ▼ −3.35% | $2.55 (−21.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers